Real Estate Blog
S.F. Port Commission to consider terms for Piers 38-40 remake amid swelling project costs
Added costs for the resiliency and infrastructure components of the Piers 38-40 redevelopment project have added over $100 million to its price tag.
Kratos purchases Birmingham property for new division acquisition
A five-building, two-story property in the metro has been acquired by a national security provider.
Clifton Park developer trying again for apartments at old Kmart
The plans call for two four-story buildings with 100 “luxury” apartments.
Iconic Morris Avenue building sold to local bar owner
A building on Morris Avenue has a new owner and new development plans.
Inventory of single-family homes in June hits highest mark in a year for Albuquerque
The median sales price for a single-family home in the Albuquerque residential market increased 8.2% — to $330,000.00 — in June 2022 when compared to the previous year.
Elks Tower owner sues former restaurant tenant Claim Jumper
The owner of The Elks Tower in Downtown Sacramento, where a Claim Jumper restaurant most recently operated, is suing the former tenant for allegedly failing to pay hundreds of thousands of dollars in rent.
Milwaukee considers appeal to block UW System demolition of former Columbia hospital
A judge’s ruling this month lets the University of Wisconsin System resume its demolition of a former Columbia St Mary’s hospital building, but the city of Milwaukee could continue fighting to save the structure through an appeal. Find out the details on the high-profile project.
Construction on $400M Snoqualmie Casino project gets underway
The expansion has been planned since the casino opened in 2008, but the tribe held off until gaining experience running the business.
Data center giant owned by Blackstone eyes major expansion in Phoenix metro
The company has most recently announced a big expansion in Texas and has previously built facilities in the Phoenix metro.
Instil Bio Life Sciences Campus in Tarzana gets $85 million loan for expansion
Instil Bio, a clinical-stage biopharmaceutical company focused on developing innovative cell therapies in the fight against cancer, plans to add a commercial manufacturing facility for research and cell therapy to its already operational clinical manufacturing site.